Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of psoriasis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction.

The investigators' hypotheses include the following:

1. Compared to in-person visits, the online care model will result in similar clinical improvement in psoriasis disease severity. 2. Compared to in-person visits, the online care model will result in similar improvements in quality of life. 3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

UC Davis Department of Dermatology

Sacramento, California, 95816, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age or older at time of consent, may be men or women.
Requiring treatment of psoriasis for medically-indicated reasons.
Capable of giving informed consent.
Able to have their skin imaged by themselves or by family members.

Exclusion criteria

Non-English speaking individuals.
Individuals lacking access to a digital camera and computer with internet connection.

Treatment and study plan

Online Teledermatology Care

Other

Patients randomized to the intervention group will have their scheduled follow-up visits online via a store and forward teledermatology modality.

Other names: Health care service modality

Conventional in Office Care

Other

Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.

Other names: Health care service modality

Primary outcomes

Psoriasis Area Severity Index (PASI)

Time frame: Every 6-8 weeks

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Sep 3, 2009
Registry last updated: Dec 13, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed